Straits Times Index
3,292.69 +10.64 (+0.32%) Nikkei
38,274.05 -131.61 (-0.34%) Hang Seng
17,763.03 +16.12 (+0.09%) FTSE 100
8,150.69 +6.56 (+0.08%) Bitcoin USD
56,889.24 -4,835.70 (-7.83%) CMC Crypto 200
1,231.83 -107.24 (-8.01%)
Quanterix Corporation (QTRX)
After hours:
| Previous close | 15.58 |
| Open | 15.47 |
| Bid | 16.10 x 400 |
| Ask | 16.17 x 500 |
| Day's range | 15.41 - 16.26 |
| 52-week range | 12.25 - 29.70 |
| Volume | |
| Avg. volume | 373,142 |
| Market cap | 616.543M |
| Beta (5Y monthly) | 1.33 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.86 |
| Earnings date | 07 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 28.40 |
Business WireQuanterix To Report First Quarter 2024 Financial Results
BILLERICA, Mass., April 29, 2024--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it will host a conference call on Wednesday, May 8, 2024 at 8:30 a.m. E.T., to discuss its first quarter 2024 financial results.
Simply Wall St.Investing in Quanterix (NASDAQ:QTRX) a year ago would have delivered you a 111% gain
Quanterix Corporation ( NASDAQ:QTRX ) shareholders might be concerned after seeing the share price drop 13% in the last...
Business WireQuanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing Infrastructure
BILLERICA, Mass., March 21, 2024--Quanterix Corporation (NASDAQ: QTRX), a leading provider of ultra-sensitive research products and high-definition diagnostics, today announced a specific partnership path for laboratories interested in offering Tau based research and diagnostic testing services. Quanterix has secured over thirty U.S. patents protecting our innovative ultra-sensitive research products and high-definition diagnostics, and we continue to secure additional patent protection, both in
